Transforming Medtech Innovation through Financial Leadership
We bridge the gap between groundbreaking Medtech innovation and the financial strategies that make it thrive—uniting story, evidence, and numbers to accelerate growth and increase profitability.
Medtech Startup
We make Medtech Startups compelling to investors by backing their storytelling with solid financial metrics
Investors
We support Medtech Venture Capital and Family Offices by providing market potential analysis and ROI metrics based on valuation models tailored to MedTech
Medtech SME’s
We provide management consulting services to medical device companies, supporting their growth with end-to-end strategic plans and EBITDA optimization programs
Fractional CFO & Strategic Leadership
Part‑time C‑level strategic financial leadership tailored to Medtech—capital planning, KPIs and performance management systems, support for investor relations and negotiations, and operational insights to optimize cash flow management as well as improve profitability.
Business Planning & Financial Projections
Plans and models that reflect product development and clinical roadmaps, early commercial validation, reimbursement assumptions, and market expansion strategies.
Cash Flow Sensitivity & Scenarios
Dynamic analyses to quantify the impact of regulatory timelines, adoption curves, pricing, and reimbursement on liquidity and runway.
Priced Round Valuations and ROI sensitivity
Going beyond financial valuation models, we have created a proper methodology tailored for early- and late-stage MedTech companies to support investors in their assessments and innovators in demonstrating professional-grade ROI analysis.
M&A valuation support
Tailored Medtech transaction financial methodologies designed to support negotiations with investment banking-style analysis and scenario simulations.
Investor Relations
Clear, consistent updates that tie KPI’s and financial performance to clinical, regulatory, and commercial milestones.
Finance with Medtech Expertise
Leveraging our experience and expertise in MedTech, we embed clinical, regulatory, evidence generation, and go‑to‑market strategies into every model and decision, allowing us to serve as true partners, not simply as financial advisors.
Story + Evidence + Numbers
While your investment narrative is cohesive and credible, it will only resonate fully if the financials provide robust evidence. Incorporating sensitivity analyses that highlight the risk–reward ratio is essential, as these insights are the foundation of every investment decision.
End‑to‑End Guidance
From seed to IPO and M&A, we provide strategic finance partnership that evolves with your company.
Results
We help medical technology companies translate their vision into measurable results.
Clinical Aspects
Our integrated method
1
We align clinical, regulatory, intellectual property, hiring, and go to market strategies prior to construction of financial models.
2
Define the business model’s major variables, identify possible ranges, and build a bespoke probability distribution.
3
Run sensitivity analysis and statistical simulations over financial model outputs, such as funding needs or enterprise valuation.
4
Embed the results into a consistent story that addresses clinical and non-clinical stakeholders with proper health economics and ROI metrics.
Good strategy is the antidote to competition. Strategic thinking is the process of developing a strategy that defines your value proposition and your unique value chain. This process includes market and competitive research as well as an assessment of the company’s capabilities and the industry forces impacting it.
Strategic plan development in a medical company involves setting a clear vision for advancing healthcare services while aligning organizational goals with patient needs and industry regulations. It requires assessing clinical strengths, technological capabilities, and market opportunities, as well as addressing challenges such as compliance and cost efficiency. A well-designed strategy ensures that resources are effectively directed toward innovation, patient care, and long-term growth in a rapidly evolving healthcare environment.
Strategic plan execution management in a medical company ensures that the goals defined in the strategy are effectively translated into action. It involves coordinating clinical teams, monitoring regulatory compliance, allocating resources, and tracking performance against milestones. By maintaining clear accountability and adapting to changes in healthcare demands, execution management helps the organization deliver high-quality patient care, drive innovation, and achieve sustainable growth
To help entrepreneurs get their act together before they talk to investors.
Contact us
Do you have questions about how Three Bridges can help your company? Send us an email and we’ll get in touch shortly.
Your details are kept strictly confidential as per our Privacy Policy.
